Smad3-ATF3 signaling mediates TGF-β suppression of genes encoding Phase II detoxifying proteins

Andrei V. Bakin, Nina V. Stourman, Konjeti R. Sekhar, Cammie Rinehart, Xuexian Yan, Michael J. Meredith, Carlos L. Arteaga, Michael L. Freeman

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

This study provides evidence that in mammary epithelial cells the pluripotent cytokine TGF-β1 repressed expression of multiple genes involved in Phase II detoxification. GCLC, the gene that encodes the catalytic subunit of the enzyme glutamate cysteine ligase, the rate-limiting enzyme in the biosynthesis of glutathione, was used as a molecular surrogate for investigating the mechanisms by which TGF-β suppressed Phase II gene expression. TGF-β was found to suppress luciferase reporter activity mediated by the human GCLC proximal promoter, as well as reporter activity mediated by the GCLC antioxidant response element, ARE4. TGF-β downregulated expression of endogenous GCLC mRNA and GCLC protein. TGF-β suppression of the Phase II genes correlated with a decrease in cellular glutathione and an increase in cellular reactive oxygen species. Ectopic expression of constitutively active Smad3E was sufficient to inhibit both reporters in the absence of TGF-β, whereas dominant negative Smad3A blocked TGF-β suppression. Smad3E suppressed Nrf2-mediated activation of the GCLC reporter. We demonstrate that TGF-β increased ATF3 protein levels, as did transient overexpression of Smad3E. Ectopic expression of ATF3 was sufficient to suppress the GCLC reporter activity, as well as endogenous GCLC expression. These results demonstrate that Smad3-ATF3 signaling mediates TGF-β repression of ARE-dependent Phase II gene expression and potentially provide critical insight into mechanisms underlying TGF-β1 function in carcinogenesis, tissue repair, and fibrosis.

Original languageEnglish (US)
Pages (from-to)375-387
Number of pages13
JournalFree Radical Biology and Medicine
Volume38
Issue number3
DOIs
StatePublished - Feb 1 2005

Fingerprint

Gene encoding
Genes
Gene Expression
Gene expression
Glutathione
Phase II Metabolic Detoxication
Antioxidant Response Elements
Glutamate-Cysteine Ligase
Detoxification
Proteins
Biosynthesis
Enzymes
Luciferases
Human Activities
Reactive Oxygen Species
Catalytic Domain
Carcinogenesis
Breast
Fibrosis
Repair

Keywords

  • ATF3
  • Free radicals
  • Glutathione
  • Nrf2
  • Smad
  • TGF-β

ASJC Scopus subject areas

  • Medicine(all)
  • Toxicology
  • Clinical Biochemistry

Cite this

Bakin, A. V., Stourman, N. V., Sekhar, K. R., Rinehart, C., Yan, X., Meredith, M. J., ... Freeman, M. L. (2005). Smad3-ATF3 signaling mediates TGF-β suppression of genes encoding Phase II detoxifying proteins. Free Radical Biology and Medicine, 38(3), 375-387. https://doi.org/10.1016/j.freeradbiomed.2004.10.033

Smad3-ATF3 signaling mediates TGF-β suppression of genes encoding Phase II detoxifying proteins. / Bakin, Andrei V.; Stourman, Nina V.; Sekhar, Konjeti R.; Rinehart, Cammie; Yan, Xuexian; Meredith, Michael J.; Arteaga, Carlos L.; Freeman, Michael L.

In: Free Radical Biology and Medicine, Vol. 38, No. 3, 01.02.2005, p. 375-387.

Research output: Contribution to journalArticle

Bakin, Andrei V. ; Stourman, Nina V. ; Sekhar, Konjeti R. ; Rinehart, Cammie ; Yan, Xuexian ; Meredith, Michael J. ; Arteaga, Carlos L. ; Freeman, Michael L. / Smad3-ATF3 signaling mediates TGF-β suppression of genes encoding Phase II detoxifying proteins. In: Free Radical Biology and Medicine. 2005 ; Vol. 38, No. 3. pp. 375-387.
@article{9d25df1ecba54277838bfd39c41612a1,
title = "Smad3-ATF3 signaling mediates TGF-β suppression of genes encoding Phase II detoxifying proteins",
abstract = "This study provides evidence that in mammary epithelial cells the pluripotent cytokine TGF-β1 repressed expression of multiple genes involved in Phase II detoxification. GCLC, the gene that encodes the catalytic subunit of the enzyme glutamate cysteine ligase, the rate-limiting enzyme in the biosynthesis of glutathione, was used as a molecular surrogate for investigating the mechanisms by which TGF-β suppressed Phase II gene expression. TGF-β was found to suppress luciferase reporter activity mediated by the human GCLC proximal promoter, as well as reporter activity mediated by the GCLC antioxidant response element, ARE4. TGF-β downregulated expression of endogenous GCLC mRNA and GCLC protein. TGF-β suppression of the Phase II genes correlated with a decrease in cellular glutathione and an increase in cellular reactive oxygen species. Ectopic expression of constitutively active Smad3E was sufficient to inhibit both reporters in the absence of TGF-β, whereas dominant negative Smad3A blocked TGF-β suppression. Smad3E suppressed Nrf2-mediated activation of the GCLC reporter. We demonstrate that TGF-β increased ATF3 protein levels, as did transient overexpression of Smad3E. Ectopic expression of ATF3 was sufficient to suppress the GCLC reporter activity, as well as endogenous GCLC expression. These results demonstrate that Smad3-ATF3 signaling mediates TGF-β repression of ARE-dependent Phase II gene expression and potentially provide critical insight into mechanisms underlying TGF-β1 function in carcinogenesis, tissue repair, and fibrosis.",
keywords = "ATF3, Free radicals, Glutathione, Nrf2, Smad, TGF-β",
author = "Bakin, {Andrei V.} and Stourman, {Nina V.} and Sekhar, {Konjeti R.} and Cammie Rinehart and Xuexian Yan and Meredith, {Michael J.} and Arteaga, {Carlos L.} and Freeman, {Michael L.}",
year = "2005",
month = "2",
day = "1",
doi = "10.1016/j.freeradbiomed.2004.10.033",
language = "English (US)",
volume = "38",
pages = "375--387",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Smad3-ATF3 signaling mediates TGF-β suppression of genes encoding Phase II detoxifying proteins

AU - Bakin, Andrei V.

AU - Stourman, Nina V.

AU - Sekhar, Konjeti R.

AU - Rinehart, Cammie

AU - Yan, Xuexian

AU - Meredith, Michael J.

AU - Arteaga, Carlos L.

AU - Freeman, Michael L.

PY - 2005/2/1

Y1 - 2005/2/1

N2 - This study provides evidence that in mammary epithelial cells the pluripotent cytokine TGF-β1 repressed expression of multiple genes involved in Phase II detoxification. GCLC, the gene that encodes the catalytic subunit of the enzyme glutamate cysteine ligase, the rate-limiting enzyme in the biosynthesis of glutathione, was used as a molecular surrogate for investigating the mechanisms by which TGF-β suppressed Phase II gene expression. TGF-β was found to suppress luciferase reporter activity mediated by the human GCLC proximal promoter, as well as reporter activity mediated by the GCLC antioxidant response element, ARE4. TGF-β downregulated expression of endogenous GCLC mRNA and GCLC protein. TGF-β suppression of the Phase II genes correlated with a decrease in cellular glutathione and an increase in cellular reactive oxygen species. Ectopic expression of constitutively active Smad3E was sufficient to inhibit both reporters in the absence of TGF-β, whereas dominant negative Smad3A blocked TGF-β suppression. Smad3E suppressed Nrf2-mediated activation of the GCLC reporter. We demonstrate that TGF-β increased ATF3 protein levels, as did transient overexpression of Smad3E. Ectopic expression of ATF3 was sufficient to suppress the GCLC reporter activity, as well as endogenous GCLC expression. These results demonstrate that Smad3-ATF3 signaling mediates TGF-β repression of ARE-dependent Phase II gene expression and potentially provide critical insight into mechanisms underlying TGF-β1 function in carcinogenesis, tissue repair, and fibrosis.

AB - This study provides evidence that in mammary epithelial cells the pluripotent cytokine TGF-β1 repressed expression of multiple genes involved in Phase II detoxification. GCLC, the gene that encodes the catalytic subunit of the enzyme glutamate cysteine ligase, the rate-limiting enzyme in the biosynthesis of glutathione, was used as a molecular surrogate for investigating the mechanisms by which TGF-β suppressed Phase II gene expression. TGF-β was found to suppress luciferase reporter activity mediated by the human GCLC proximal promoter, as well as reporter activity mediated by the GCLC antioxidant response element, ARE4. TGF-β downregulated expression of endogenous GCLC mRNA and GCLC protein. TGF-β suppression of the Phase II genes correlated with a decrease in cellular glutathione and an increase in cellular reactive oxygen species. Ectopic expression of constitutively active Smad3E was sufficient to inhibit both reporters in the absence of TGF-β, whereas dominant negative Smad3A blocked TGF-β suppression. Smad3E suppressed Nrf2-mediated activation of the GCLC reporter. We demonstrate that TGF-β increased ATF3 protein levels, as did transient overexpression of Smad3E. Ectopic expression of ATF3 was sufficient to suppress the GCLC reporter activity, as well as endogenous GCLC expression. These results demonstrate that Smad3-ATF3 signaling mediates TGF-β repression of ARE-dependent Phase II gene expression and potentially provide critical insight into mechanisms underlying TGF-β1 function in carcinogenesis, tissue repair, and fibrosis.

KW - ATF3

KW - Free radicals

KW - Glutathione

KW - Nrf2

KW - Smad

KW - TGF-β

UR - http://www.scopus.com/inward/record.url?scp=11344292584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11344292584&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2004.10.033

DO - 10.1016/j.freeradbiomed.2004.10.033

M3 - Article

C2 - 15629866

AN - SCOPUS:11344292584

VL - 38

SP - 375

EP - 387

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 3

ER -